Objectives-To determine the effect, if any, of an increasing maternal body mass index (BMI) on sonographically diagnosed oligohydramnios in late gestation and how it subsequently affects obstetric and neonatal outcomes.
A n increased maternal body mass index (BMI) can impair sonographic visualization of fetal anatomy, 1,2 estimation of fetal weight, 3, 4 and detection of fetal anomalies. 5, 6 Indeed, more than 1 in 4 obese pregnant women have incomplete secondtrimester fetal anatomic sonographic surveys compared to less than 1 in 20 normal-weight pregnant women. 7 The panniculus increases the distance between the transducer and the target areas of interest. An increased depth of penetration scatters the ultrasonic beam, degrades image resolution, and may produce images that are fuzzy and high in artifacts. Furthermore, some operators may lift the panniculus and scan underneath it, whereas others may scan above it, possibly producing different results. Despite the substantial influence of sonographic findings on obstetric management, our understanding of the limitations imposed by maternal obesity remains underdeveloped, especially in late gestation.
It is possible that pockets of amniotic fluid are not adequately visualized in obese patients. Furthermore, it is not clear at which BMI threshold, if any, that this situation may occur. Throughout pregnancy, the quantity of amniotic fluid is tightly regulated. 8 At term, the volume begins to decline from a peak at 34 to 36 weeks. Oligohydramnios, defined alternatively as an amniotic fluid index (AFI) of less than 5 cm or a single deepest pocket of less than 2 cm, is associated with a higher rate of labor induction, meconium-stained amniotic fluid, neonatal intensive care unit admissions, low Apgar scores, intrauterine growth restriction, neonatal deaths, and cesarean delivery for a nonreassuring fetal heart tracing. [9] [10] [11] [12] Few studies have evaluated whether an increasing maternal BMI affects sonographic assessment of the amniotic fluid volume in late gestation. Those that have addressed this question have produced contradictory results and relied on dichotomous thresholds for obesity rather than examining the BMI as a continuous variable or by standard BMI classification groups defined by the World Health Organization. [13] [14] [15] The objective of this study was to examine the effect, if any, of an increasing maternal BMI on sonographically diagnosed oligohydramnios in late gestation and to determine whether it subsequently affects obstetric and neonatal outcomes.
Materials and Methods
This retrospective cohort study evaluated all women with singleton gestations who had 1 or more obstetric sonographic examinations performed at 40 to 42 weeks' gestational age in the Antepartum Testing Unit at North Shore University Hospital between January 1, 2010, and December 31, 2013. At our institution, antepartum fetal surveillance is routinely initiated at 40 weeks' gestation. Patients were included in the study if they had valid pregnancy dating (based on the menstrual history and confirmed by first-trimester sonography), had an AFI measurement at or beyond 40 weeks' gestation, and ultimately delivered at North Shore University Hospital. Ten experienced registered diagnostic medical sonographers performed the sonographic examinations, and maternal-fetal medicine attending physicians reviewed their findings. Sonography was performed with either a Voluson E8 or Voluson 730 system (GE Healthcare, Milwaukee, WI) or an iU22 system (Philips Healthcare, Bothell, WA). Exclusion criteria included patients with multiple gestations and fetal anomalies. Additionally, underweight women (prepregnancy BMI < 18.5 kg/m 2 ) were excluded because of higher rates of oligohydramnios and fetal growth restriction. 16 If patients had multiple pregnancies during the study period that exceeded 40 weeks' gestation and were managed expectantly, only the first one was included for analysis. The Northwell Health Human Research Protection Program and Institutional Review Board approved the study protocol.
Data were obtained from the obstetric sonography database. Medical records were reviewed to obtain baseline characteristics of the study population, including maternal age, gravidity, parity, race/ethnicity, BMI, medical and surgical histories, and obstetric and gynecologic histories. The BMI documented on admission to labor and delivery was collected. The prepregnancy BMI (or, if unavailable, first-trimester BMI) was collected when available. Gestational weight gain was calculated and categorized as excessive if it exceeded the Institute of Medicine recommendations. 17 Patients with chronic medical conditions such as chronic hypertension, pregestational diabetes, asthma, and thyroid disorders were identified.
Patients were divided into 5 groups based on their late pregnancy BMI using the World Health Organization classification criteria: normal weight (18.5-24.9 kg/ m A quantitative assessment of the amniotic fluid volume was performed by sonography. In each case, the abdomen was divided into 4 quadrants. The linea nigra was used to delineate the right and left divisions, and the umbilicus was used to delineate the upper and lower divisions. The transducer was oriented longitudinally and perpendicular to the plane of the floor. The single deepest pocket in each quadrant not containing the umbilical cord or fetal parts was measured in centimeters with the use of color Doppler imaging, and the sum of these 4 measurements was the AFI. The last documented AFI before delivery was used for our analysis.
Comparisons between groups for continuous variables were performed by either the Mann-Whitney test or the t test, as appropriate. Either the Fisher exact test or v 2 test was used, as appropriate, to examine associations between categorical variables. Spearman correlations were used to determine the strength of correlations between continuous variables (eg, BMI and AFI). Statistical significance was defined as P < .05.
A multivariable logistic regression was performed to examine the association between oligohydramnios and the maternal BMI. A similar regression analysis was performed to identify factors predictive of primary cesarean delivery. In each case, these models adjusted for maternal age (35 versus < 35 years), parity (nulliparous versus multiparous), gestational weight gain (exceeded Institute of Medicine guidelines), gestational diabetes, and hypertension. A backward-selection algorithm was then applied to arrive at a parsimonious model. The Hosmer-Lemeshow goodness-of-fit statistic and area under the receiver operating characteristic curve were used to assess model fit. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) are presented. All analyses were generated with SAS version 9.3 software (SAS Institute Inc, Cary, NC).
Results
During the study period, 2054 singleton pregnancies were evaluated by sonography at 40 to 42 weeks' gestation to assess fetal well-being. After applying exclusion criteria, 1671 patients remained for analysis ( Figure 1 ). The overall frequency of oligohydramnios was 11.3% (n 5 189). The study population was predominantly white and nulliparous, with a mean age 6 SD of 30.9 6 5.3 years. The mean prepregnancy BMI was 25.3 6 5.2 kg/m 2 , and the mean late-pregnancy BMI was 31.0 6 5.4 kg/m 2 . Patients in the higher BMI groups were more likely to be nulliparous and have chronic medical conditions ( Table 1 ). There was no difference in maternal age between BMI groups. A higher proportion of African Americans and a lower proportion of Asians were found in the high BMI groups (P < .04). Gestational weight gain increased with each successive BMI grouping except for the class III obesity group, possibly because of more aggressive counseling.
There were no differences in the rates of oligohydramnios among the 5 late-pregnancy BMI groups (Table 2 ). In addition, there was no significant linear correlation between the late-pregnancy maternal BMI and AFI (q 5 -0.032; P 5 .19). There was a weak inverse relationship noted between the prepregnancy maternal BMI and AFI in late gestation (q 5 -0.051; P < .03). Furthermore, when comparing patients with a normal prepregnancy BMI (n 5 952) to those who were obese (class I, II, or III) before pregnancy (n 5 271), there was a small decrease in the final documented AFI before delivery (12.3 6 5.4 versus 11.4 6 5.5 cm; P < .01). Gestational weight gain had no 
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significant effect on the frequency of oligohydramnios, but a weakly positive correlation with the AFI was noted (q 5 0.06; P < .02). Patients with oligohydramnios in our study population were more likely to be nulliparous than patients without oligohydramnios (73.5% versus 65.3%; P < .03). There was no difference in the frequency of oligohydramnios based on maternal age, race/ ethnicity or chronic medical conditions. In the final multivariable logistic regression model, only nulliparity was associated with oligohydramnios (P < .05; OR, 1.41; 95% CI, 1.00-1.98). The c statistic, a measure of the discriminative power of the logistic regression model, was 0.54, indicating that the probability of correctly predicting oligohydramnios was not much better than random chance.
Obstetric outcomes differed between the 5 BMI groups (Table 2 ) and were further affected by oligohydramnios, when present. The rate of primary cesarean delivery increased with each successive BMI group, and the rates of both spontaneous vaginal delivery and surgical vaginal delivery decreased with each successive BMI group (P < .001). Women in the class III obesity group had an approximately 3-fold higher rate of primary cesarean delivery than women in the normal BMI group (47.2% versus 14.5%) and a 2-fold higher rate than women in the overweight BMI group (47.2% vs. 23.4%). However, there were no differences found in the indications for primary cesarean delivery among the BMI groups. Approximately half were performed for dystocia and one-fourth for a nonreassuring fetal status.
Patients with oligohydramnios were more likely to have a cesarean delivery than patients with a normal AFI (38.6% versus 30.4%; P < .03; OR, 1.44; 95% CI, 1.06-1.97). Among patients who had a primary cesarean delivery (n 5 484), a nonreassuring fetal status was a more frequent indication in women with oligohydramnios compared to those with a normal AFI (38.1% versus 25.4%; P < .05; OR, 1.81; 95% CI, 1.04-3.14). Among patients with oligohydramnios, 28.1% of those with a late-pregnancy BMI of less than 30 kg/m 2 (n 5 89) had a primary cesarean delivery compared to 51.4% of those with a late-pregnancy BMI of greater than 35 kg/m 2 (n 5 37; P < .02; OR, 2.70; 95% CI, 1.22-5.97) and 60% of those with a late-pregnancy BMI Gestational weight gain data available for 96.6% of patients.
of greater than 40 kg/m 2 (n 5 15; P < .02; OR, 3.84; 95% CI, 1.24-11.91). In the final multivariable logistic regression model, a high BMI, nulliparity, and excessive gestational weight gain were associated with primary cesarean delivery (Table 3) . Although there appeared to be an additive effect of an increasing BMI and oligohydramnios on the rate of primary cesarean delivery (Figure 2) , oligohydramnios was not significant in the regression model. The c statistic was 0.737, indicating a reasonable ability of the model to predict primary cesarean delivery.
Neonatal outcomes also differed between the 5 BMI groups ( Table 2 ). The mean birth weight increased with each successive BMI category (P < .001). Also, there was a significant positive correlation noted between the AFI and birth weight (q 5 0.25; P < .0001). In our study population, macrosomia (>4500 g) was uncommon (1.6%), and no difference in the frequency of macrosomia was found between BMI groups. There was no difference in the frequency of Apgar scores of 7 or lower at 1 and 5 minutes between BMI groups. In addition, there was no difference in Apgar scores in patients with and without oligohydramnios.
Discussion
Although obesity is known to impose considerable limitations on sonographic visualization during pregnancy, no large studies have investigated an association between Data are presented as mean 6 SD and number (percent) where applicable.
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an increasing maternal BMI and the rate of oligohydramnios in late gestation, both of which are known to affect obstetric outcomes and management. Our large retrospective study found no association between the latepregnancy BMI and AFI after adjusting for baseline characteristics between groups. The study population was predominantly nulliparous, which was in large part due to a lower rate of expectant management in multiparous patients at 40 weeks' gestation or later. Obstetric and neonatal outcomes were generally consistent with prior studies. As expected, an increasing maternal BMI was linearly associated with an increased risk of primary cesarean delivery. 18, 19 Oligohydramnios was similarly associated with an increased risk of cesarean delivery, and it was more frequently attributable to nonreassuring fetal heart tracings. 9, 20 Although some prior studies have reported an increased rate of surgical vaginal deliveries in patients with oligohydramnios, we did not observe this finding in our study population. These differences are likely attributable to variations in clinical practice based on geography and the level of familiarity and experience with the technique. 21 Also as expected, an increasing maternal BMI was associated with an increasing neonatal birth weight. Nonetheless, some adverse fetal outcomes thought to be associated with maternal obesity were not prevalent, including macrosomia and a nonreassuring fetal status 22, 23 ; this finding can be attributed to the fact that our study population predominantly consisted of uncomplicated pregnancies in otherwise healthy mothers that were managed expectantly.
Our study had several strengths, including the large sample size and the high level of training and experience of the sonographers who performed the sonographic examinations. In addition, there was a sufficient number of observations across the 5 BMI categories, which facilitated comparisons between groups. Our study also had some limitations, including the retrospective design and reliance on self-reported weight and height data, which were documented on admission to the hospital for delivery and subject to a recall or reporting bias. Pregnant women underreport weight more frequently than nonpregnant women. 24 Additionally, this underreporting becomes more common with increases in the prepregnancy BMI and gestational weight gain. 25 However, according to one large study, the discrepancy between self-reported and measured weight at delivery was less than 3 lb on average. 25 Differential misclassification of exposure (obesity), in which the probability of being misclassified differs across groups, may bias either toward or away from the null (normal AFI). Nevertheless, since the BMI was evaluated both categorically (by BMI classification) and as a continuous variable, the overall impact of incorrect BMI categorization should have been minimal. It should also be noted that the physicians and midlevel providers treating patients in the labor and delivery department were not blinded to the results of amniotic fluid estimation, and this knowledge may have influenced the mode of delivery. Also, the single deepest pocket was not directly evaluated in this study because, at our institution, when biophysical Oligohydramnios was not significant in this model.
profiles are performed, the amniotic fluid component is commonly reported in a dichotomous fashion (>2 cm present/absent) and not necessarily quantified in cases with grossly adequate amniotic fluid. The diagnosis of oligohydramnios, especially at term, is frequently made on the basis of the lower threshold for diagnosis: the AFI rather than the single deepest pocket. Thus, clinical management decisions for this population are in many cases a product of the AFI and not the single deepest pocket, despite a growing body of literature that suggests that this approach offers no significant reduction in adverse perinatal outcomes. [26] [27] [28] Sonographic evaluation of the AFI may be less affected by the BMI than other aspects of fetal evaluation in late gestation. Amniotic fluid, which typically appears as anechoic spaces interspersed between fetal limbs and the uterine wall, is easier to visualize than fine details of fetal anatomy that may require imaging with high spatial and contrast resolution. In obese women, the mean depth of insonation is deeper than in nonobese women. 29 The ultrasonic waves must travel a greater distance, which results in greater absorption and dispersion in the surrounding tissues and ultimately produces weaker ultrasonic waves. 30 With less energy, there is increased backscatter, which leads to a decreased signal-to-noise ratio and degraded image quality. Visualization in such cases may be improved by the use of a low-frequency transducer (to allow greater penetration), harmonic imaging, compound imaging, and postprocessing filters, including speckle reduction. 30 In summary, this study found no association between the late-pregnancy BMI and AFI. This finding suggests that there is no difference in the rate of oligohydramnios in obese patients compared to nonobese patients and, therefore, no altered clinical management resulting either from an erroneous diagnosis or a physiologic difference. However, we also observed that an increasing BMI in conjunction with oligohydramnios significantly increases the risk of primary cesarean delivery. It should be noted that the BMI is an indirect measure of body fat and may not reflect abdominal adiposity. It is possible that the waist circumference or waist-to-hip ratio is better correlated with deficient sonographic visualization than the BMI. Future studies should prospectively evaluate these metrics and their association, if any, with sonographic measurement of the amniotic fluid volume because they are not typically measured in routine obstetric care.
